Matthew A Berger Md Pc Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 340 Montage Mountain Rd, Moosic, PA 18507 Phone: 570-346-3686 |
Danilo De Soto Md Pc Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 340 Montage Mountain Rd, Moosic, PA 18507 Phone: 570-344-9266 |
John G Kuna Psy D & Associates Llc Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 4101 Birney Ave, Moosic, PA 18507 Phone: 570-961-3361 Fax: 570-961-3364 |
Hamidian Training Institute Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 4113 Birney Ave Ste 8, Moosic, PA 18507 Phone: 570-489-5561 Fax: 570-489-5563 |
Coh Mental Health Wellness Community/Behavioral Health Agency Medicare: Medicare Enrolled Practice Location: 500 Main St, Moosic, PA 18507 Phone: 570-342-0143 Fax: 570-342-0143 |
Geisinger Behavioral Health Center Northeast Clinic - Adult Mental Health Medicare: Medicare Enrolled Practice Location: 60 Glenmaura National Blvd, Moosic, PA 18507 Phone: 215-581-3820 |
News Archive
King's College London has entered into an agreement with skincare company Aethic to develop the first sunscreen based on MAA's (mycosporine-like amino acids), produced by coral.
FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products and medical informatics solutions, will showcase its evolving Enterprise Imaging portfolio of Synapse integrated solutions and spotlight enhanced features and next generation upgrades at the Radiological Society of North America 2016 conference and exhibition held November 27 - December 2, 2016 at McCormick Center in Chicago, Illinois.
Alzheimer's disease (AD) may progress more rapidly in people with high blood pressure or a form of irregular heartbeat, atrial fibrillation, according to results of a Johns Hopkins study published in the Nov. 6, 2007, issue of Neurology.
Affymax, Inc. and Takeda Pharmaceutical Company Limited, today announced that the companies have decided on a preliminary strategic path forward for the investigational drug, Hematideā¢/peginesatide, for the treatment of anemia in chronic renal failure patients in the United States.
› Verified 3 days ago